These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10943323)

  • 1. T cell receptor peptides for the vaccination therapy of multiple sclerosis.
    Brocke S
    Ernst Schering Res Found Workshop; 2000; (30):167-79. PubMed ID: 10943323
    [No Abstract]   [Full Text] [Related]  

  • 2. [The trimolecular complex as a target for specific immunotherapy in experimental autoimmune encephalomyelitis--applications for multiple sclerosis and other human autoimmune disease].
    Miller A; Weiner HL; Abramsky O
    Harefuah; 1992 Aug; 123(3-4):110-5. PubMed ID: 1516860
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunopathogenic mechanisms in experimental allergic encephalomyelitis.
    Kálmán B; Lublin FD
    Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):182-8. PubMed ID: 7683223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease.
    Steinman L
    Adv Immunol; 1991; 49():357-79. PubMed ID: 1713016
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunity to T cell receptor peptides: theory and applications.
    Offner H; Hashim GA; Vandenbark AA
    Regul Pept; 1994 May; 51(2):77-90. PubMed ID: 8059014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis and their application for new therapeutic strategies.
    Martin R
    J Neural Transm Suppl; 1997; 49():53-67. PubMed ID: 9266414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of T cell receptor (TCR) of organ-specific autoimmune disease-inducing T cells and TCR-based immunotherapy with DNA vaccines.
    Matsumoto Y
    J Neuroimmunol; 2000 Oct; 110(1-2):1-12. PubMed ID: 11024529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focusing on the human T cell receptor for antigen.
    Grunewald J
    Sarcoidosis; 1994 Mar; 11(1):61-5. PubMed ID: 8036347
    [No Abstract]   [Full Text] [Related]  

  • 9. The T lymphocyte in experimental allergic encephalomyelitis.
    Zamvil SS; Steinman L
    Annu Rev Immunol; 1990; 8():579-621. PubMed ID: 2188675
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoreactive T cells in multiple sclerosis.
    Zhang J; Weiner HL; Hafler DA
    Int Rev Immunol; 1992; 9(3):183-201. PubMed ID: 1285060
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigen-specific T cells in autoimmune diseases with a focus on multiple sclerosis and experimental allergic encephalomyelitis.
    Xiao BG; Link H
    Cell Mol Life Sci; 1999 Oct; 56(1-2):5-21. PubMed ID: 11213261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell receptor peptide therapy for autoimmune disease.
    Vandenbark AA; Chou YK; Bourdette DN; Whitham R; Hashim GA; Offner H
    J Autoimmun; 1992 Apr; 5 Suppl A():83-92. PubMed ID: 1503638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis.
    Zhang X; Hupperts R; De Baets M
    Immunol Res; 2003; 28(1):61-78. PubMed ID: 12947225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the immunopathogenesis of multiple sclerosis.
    Hellings N; Raus J; Stinissen P
    Immunol Res; 2002; 25(1):27-51. PubMed ID: 11868933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models for multiple sclerosis.
    Owens T
    Adv Neurol; 2006; 98():77-89. PubMed ID: 16400828
    [No Abstract]   [Full Text] [Related]  

  • 16. Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis.
    Steinman L
    J Exp Med; 2001 Sep; 194(5):F27-30. PubMed ID: 11535639
    [No Abstract]   [Full Text] [Related]  

  • 17. T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.
    O'Brien K; Gran B; Rostami A
    Immunotherapy; 2010 Jan; 2(1):99-115. PubMed ID: 20231863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiotypic regulation directed at T-cell receptor determinants.
    Vandenbark AA; Hashim GA; Offner H
    Chem Immunol; 1995; 60():100-25. PubMed ID: 7857524
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.
    Stinissen P; Raus J; Zhang J
    Crit Rev Immunol; 1997; 17(1):33-75. PubMed ID: 9034723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerogenic vaccines for Multiple sclerosis.
    Mannie MD; Curtis AD
    Hum Vaccin Immunother; 2013 May; 9(5):1032-8. PubMed ID: 23357858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.